The proxy is out for the meeting on June 24. There are several issues that are on the table to be voted on. The more important of them is the issue on increasing the authorized shares. I urge you all to please vote no on this matter. ENOUGH is ENOUGH. No more dilutions!!! The rationale for more funds to finance drug production and marketing has been already satisfied. THis was the reason for the last 2 dilutions. Again, ENOUGH IS ENOUGH.
The company has yet to prove itself worthy. No more dilutions!!! I don't want to be paying bonuses to people who has yet to show their value. Pls vote NO!!!
I am also concerned about misuse of capital reserved for operating activities. What kind of business practice is that, you take on new debt/dilution of existing stock, when you already had some funds for operating activities reserved? I dont know guys, I am long on 'house' money, but I am a little vary of this entire saga now...
"The Compensation Committee and Board of Directors reviewed corporate goals established in March 2008 and determined that significant progress has been made in terms of 1) preparation and filing the Ampligen(r) NDA with the Federal Drug Administration; and 2) with the receipt of recent funding for operating activities, funds previously reserved for operating activities could be used to pay 2008 bonus."